Stockreport

Merck, Pfizer drug combo extends kidney cancer survival -study [Reuters]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck, Pfizer drug combo extends kidney cancer survival: study (Reuters) - A combination of Merck & Co’s immunotherapy Keytruda and Pfizer Inc’s Inlyta helped patients w [Read more]